San Francisco-based virtual care company, Curai Health, which uses artificial intelligence to provide chat-based primary care at a lower cost, raised US$ 27.5M in Series B funding on 16 December 2020.
The Series B funding was led by Morningside Ventures. Other participants include existing investors General Catalyst and Khosla Ventures. This round of funding brings Curai’s total funding to approximately US$ 57 million. As part of today’s deal, Stephen Bruso from Morningside Ventures will join its board.
Curai Health will utilize the funding to continue innovating its technology and expand its services and footprint.
About Curai Health
Founded in 2017 by Anitha Kannan, Neal Khosla, Neil Hunt and Xavier Amatriain, Curai Health provides chat-based primary care to patients. It is built for clinicians and aims to reduce the costs of care. Curai Health blends the best in high-touch clinical care, sophisticated artificial intelligence (AI) and the most robust clinical data sources. It is a learning healthcare system that creates a sustainable and scalable primary care model that can meet the demands of an exploding global population.
Curai was previously available only direct-to-consumer, but it will now support enterprise partnerships, including payers, employers and public-sector organizations. Curai Health aims to partner with enterprises that want an affordable primary care option for everyone in their organization, especially those with people who sometimes struggle with the cost of care, like hourly employees, gig workers and those with high-deductible health plans.
“AI has the power to scale the care provided by a finite number of physicians so that it can meet the demands of a global population. We’ve dedicated countless hours to in-depth clinical and technical R&D to ensure our system gets smarter, more efficient and increasingly cost-effective after every patient encounter. We aren’t interested in the 10- to 20-percent cost savings that most virtual care platforms aspire to deliver. We’re working toward 10 and, eventually 100x, care-delivery cost reductions,” said Neal Khosla, co-founder and CEO of Curai Health.
Curai Health is accessible to patients 24/7. Patient care teams are led by U.S. licensed physicians and medically trained Clinical Associates, who are both supported by the AI.
The AI helps in suggestions and automating more low-value tasks. It also will listen and learn from each patient encounter, ensuring it gains a greater understanding of medical language, symptomatology and condition diagnosis, while also delivering increasingly high-quality patient care.
What Investors have to say
“Curai Health’s technological prowess, bold vision and incredible leadership are what make for a good investment. This is an investment with potential for global impact, giving access to a potentially life-saving car. As an investor, I can’t think of a better proposition: make everyone, everywhere healthier,” said Gerald Chan, Co-Founder of Morningside Group.
We try our best to fact check and bring the best, well-researched and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback and thank you for stopping by!